- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Post Polycythemia-Vera Myelofibrosis in United States
Total 169 results
-
Fox Chase Cancer CenterRecruitingPrimary Myelofibrosis | Polycythemia Vera | Chronic Myelomonocytic Leukemia | Essential Thrombocytosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States
-
John MascarenhasMassachusetts General Hospital; Montefiore Medical CenterCompletedPrimary Myelofibrosis | Polycythemia Vera | Post-essential Thrombocythemia Myelofibrosis | Chronic Phase MyelofibrosisUnited States
-
Vanderbilt-Ingram Cancer CenterActive, not recruitingPolycythemia Vera | MyelofibrosisUnited States
-
Incyte CorporationRecruitingMyelofibrosis | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndrome | Relapsed or Refractory Primary Myelofibrosis | Secondary Myelofibrosis (Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis) | ET...United States, Spain, Japan, Italy, Finland, United Kingdom, Canada, Netherlands
-
M.D. Anderson Cancer CenterS*BIOCompleted
-
M.D. Anderson Cancer CenterCelgeneCompleted
-
Novartis PharmaceuticalsCompletedPrimary Myelofibrosis (PMF) | Post Polycythaemia Myelofibrosis (PPV MF) | Post Essential Thrombocythaemia Myelofibrosis (PET-MF)United Kingdom
-
Hoffmann-La RocheCompletedPrimary Myelofibrosis | Polycythemia Vera | Post-Essential Thrombocythemia MyelofibrosisUnited States, Netherlands, Italy, United Kingdom, Canada, France, Germany, Israel
-
Incyte CorporationCompletedPolycythemia Vera | Myelofibrosis | ThrombocythemiaSpain, United States, Germany, Austria, Belgium, Italy, Poland
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI); Myeloproliferative Disorders-Research ConsortiumCompletedPolycythemia Vera | Essential Thrombocythemia | Idiopathic MyelofibrosisUnited States, Italy
-
TargeGenCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedChronic Myeloproliferative Disorders | Secondary MyelofibrosisUnited States
-
ExelixisTerminatedMyeloproliferative Disorders | Polycythemia Vera | Thrombocythemia, Essential | MyelofibrosisUnited States
-
Roswell Park Cancer InstituteCephalon, Inc.TerminatedPrimary Myelofibrosis | Polycythemia Vera | Essential ThrombocythemiaUnited States
-
Incyte CorporationCompletedPolycythemia Vera | Thrombocytosis | MyelofibrosisUnited States
-
Gilead SciencesTerminated
-
National Institutes of Health Clinical Center (CC)CompletedPolycythemia Vera | Chronic Myeloproliferative Disorders | Essential Thrombocytosis | Idiopathic Myelofibrosis | NeutrophilsUnited States
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI); Myeloproliferative Disorders-Research ConsortiumCompletedPolycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Idiopathic MyelofibrosisUnited States, Italy
-
University of UtahNational Cancer Institute (NCI); Myeloproliferative Disorders-Research ConsortiumCompletedPolycythemia Vera | Essential Thrombocythemia | MyelofibrosisUnited States
-
Novartis PharmaceuticalsCompletedMyelofibrosisFrance, United Kingdom, Belgium, Germany, Netherlands, Italy, Austria, Spain, Sweden
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Polycythemia Vera | Essential ThrombocythemiaUnited States
-
S*BIOCompletedMyeloproliferative Disorders | Polycythemia Vera | Essential Thrombocythemia | MyelofibrosisUnited States, Australia
-
Ronald HoffmanNational Cancer Institute (NCI); Myeloproliferative Disorders-Research ConsortiumUnknownPolycythemia Vera | Essential Thrombocythemia | MyelofibrosisUnited States
-
Novartis PharmaceuticalsCompletedPolycythemia Vera (PV)United States
-
Gilead SciencesCompleted
-
University of California, IrvineRecruitingPolycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Myeloproliferative Neoplasm | MPNUnited States
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Polycythemia Vera | Essential ThrombocythemiaUnited States
-
Kartos Therapeutics, Inc.RecruitingMyelofibrosisUnited States, France, Australia, Spain, Germany, Bulgaria, Israel, Italy, Poland
-
Eli Lilly and CompanyCompletedPrimary Myelofibrosis | Myeloproliferative Disorders | Polycythemia Vera | Thrombocythemia, EssentialUnited States
-
SyntaraParexelRecruitingMyelofibrosisTaiwan, Australia, Korea, Republic of, United States
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)Canada, United States, Australia
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)United States, Canada, Australia
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI); Myeloproliferative Disorders-Research ConsortiumCompletedPolycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Idiopathic Myelofibrosis | Myeloproliferative DiseaseUnited States, Canada, Italy, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Polycythemia Vera | Essential Thrombocythemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Chronic Neutrophilic Leukemia | Myeloid Neoplasm | Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative | Myelodysplastic/Myeloproliferative... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterNovartisTerminated
-
Ionis Pharmaceuticals, Inc.RecruitingPhlebotomy Dependent Polycythemia VeraUnited States, Canada, Hungary, United Kingdom, Australia, Poland
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Chronic Myelomonocytic LeukemiaUnited States
-
Queen's University, BelfastMayo Clinic; University Hospital Southampton NHS Foundation Trust; University... and other collaboratorsCompletedPrimary Myelofibrosis | Polycythemia Vera | Essential ThrombocythemiaUnited Kingdom
-
Weill Medical College of Cornell UniversityCompleted
-
University of California, IrvineCompletedPolycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Myeloproliferative Disorder | Myeloproliferative SyndromeUnited States
-
Eli Lilly and CompanyCompletedPolycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Myeloproliferative Neoplasms ofUnited States
-
Weill Medical College of Cornell UniversityBristol-Myers SquibbTerminated
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Chronic Myelomonocytic Leukemia | Myeloproliferative Neoplasm | Paroxysmal Nocturnal Hemoglobinuria | de Novo Myelodysplastic Syndrome | Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative | Refractory Anemia | Refractory Anemia With... and other conditionsUnited States
-
ExelixisTerminated
-
Incyte CorporationNovartisCompletedMyelofibrosisFrance, United Kingdom, China, United States, Netherlands, Germany, Italy, Austria
-
Protagonist Therapeutics, Inc.Enrolling by invitationPolycythemia VeraUnited States
-
Ohio State University Comprehensive Cancer CenterIncyte Corporation; Jazz PharmaceuticalsRecruitingPolycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Secondary Acute Myeloid Leukemia | Myeloproliferative NeoplasmUnited States
-
University of OklahomaOSI PharmaceuticalsTerminatedPolycythemia VeraUnited States
-
Ronald HoffmanNational Cancer Institute (NCI); Roche Pharma AG; Myeloproliferative Disorders-Research...CompletedHigh Risk Polycythemia Vera | High Risk Essential ThrombocythemiaUnited States, Italy, United Kingdom, France
-
ItalfarmacoRecruitingPolycythemia VeraUnited States